Velocity Clinical Research in Savannah, GA is a leading research site that specializes in conducting clinical trials related to vaccines and a wide range of health conditions. With a commitment to providing the highest quality of patient care, the experienced research team at Velocity conducts trials in accordance with ICH and FDA guidelines, ensuring compliance with GCP. Founded in 2012 as part of Meridian Clinical Research and acquired by Velocity in 2022, this location is conveniently situated near medical offices and a local hospital, making it easily accessible to diverse populations of patients.
Under the oversight of board-certified physicians, including Principal Investigators Dr. Paul Bradley and Dr. David J. Gaskin, Velocity Clinical Research in Savannah is dedicated to advancing medicine through research. With decades of research experience and a team trained in clinical research regulations, the site provides a professional and caring environment for study participants. As a trusted resource for those interested in participating in clinical trials, Velocity Clinical Research is at the forefront of medical advancements in the Savannah area.
Generated from the website
